Answer
Aclasta treats osteoporosis in post-menopausal women and adult men at increased fracture risk, including those with a recent low-trauma hip fracture or osteoporosis associated with long-term systemic glucocorticoid therapy, and Paget’s disease of bone in adults.
Sources for this answer
- Aclasta 5 mg solution for infusionSandoz Limited · emc · SmPC §4.1 Therapeutic Indications · Version 24Document updated
Sources checked